Your browser doesn't support javascript.
loading
European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children.
de Ville de Goyet, Jean; Baumann, Ulrich; Karam, Vincent; Adam, René; Nadalin, Silvio; Heaton, Nigel; Reding, Raymond; Branchereau, Sophie; Mirza, Darius; Klempnauer, Jürgen L; Fischer, Lutz; Kalicinski, Piotr; Colledan, Michele; Lopez Santamaria, Manuel; de Kleine, Ruben H; Chardot, Christophe; Yilmaz, Sezai; Kilic, Murat; Boillot, Olivier; di Francesco, Fabrizio; Polak, Wojciech G; Verkade, Henkjan J.
Afiliación
  • de Ville de Goyet J; Department for the Treatment and Study of Pediatric Abdominal Diseases and Abdominal Transplantation, Istituto di Ricovero e Cura a Carattere Scientifico, Palermo, Italy.
  • Baumann U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Karam V; Paediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany.
  • Adam R; European Liver and Intestine Transplant Association, Padua, Italy.
  • Nadalin S; European Liver Transplant Registry, Assistance Publique-Hôpitaux de Paris Hôpital Paul Brousse, Université Paris-Sud, Inserm U 935, Villejuif, France.
  • Heaton N; European Liver and Intestine Transplant Association, Padua, Italy.
  • Reding R; European Liver Transplant Registry, Assistance Publique-Hôpitaux de Paris Hôpital Paul Brousse, Université Paris-Sud, Inserm U 935, Villejuif, France.
  • Branchereau S; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
  • Mirza D; King's College Hospital, London, UK.
  • Klempnauer JL; Cliniques Universitaires Saint Luc, Université catholique de Louvain, Brussels, Belgium.
  • Fischer L; Service de Chirurgie Viscérale Pédiatrique Bicêtre University Hospital, Faculty of Medicine Paris-Sud, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, France.
  • Kalicinski P; Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Colledan M; Klinik für Viszeral und Transplantations-chirurgie, Hannover Medical School, Hannover, Germany.
  • Lopez Santamaria M; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • de Kleine RH; Department of Pediatric and Transplant Surgery, Children's Memorial Health Institute, Warsaw, Poland.
  • Chardot C; Università degli studi di Milano Bicocca, ASST Giovanni XXIII, Department of Organ Failure and Transplantation, Bergamo, Italy.
  • Yilmaz S; Pediatric Surgery Department, Hospital Infantil Universitario ''La Paz,", Madrid, Spain.
  • Kilic M; Department of Surgery, Section of Hepato-Pancreatico-Biliary Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Boillot O; Service de Chirurgie Pediatrique, Hôpital Necker Enfants Malades, Paris, France.
  • di Francesco F; Liver Transplantation Institute, Inonu University, Malatya, Turkey.
  • Polak WG; Liver Transplant Program, Izmir Kent Hospital, Izmir, Turkey.
  • Verkade HJ; Pediatric Liver Transplant Surgery, Hôpital Edouard Herriot, Lyon, France.
Hepatology ; 75(3): 634-645, 2022 03.
Article en En | MEDLINE | ID: mdl-34724224
ABSTRACT
BACKGROUND AND

AIMS:

The European Liver Transplant Registry (ELTR) has collected data on liver transplant procedures performed in Europe since 1968. APPROACH AND

RESULTS:

Over a 50-year period (1968-2017), clinical and laboratory data were collected from 133 transplant centers and analyzed retrospectively (16,641 liver transplants in 14,515 children). Data were analyzed according to three successive periods (A, before 2000; B, 2000-2009; and C, since 2010), studying donor and graft characteristics and graft outcome. The use of living donors steadily increased from A to C (A, n = 296 [7%]; B, n = 1131 [23%]; and C, n = 1985 [39%]; p = 0.0001). Overall, the 5-year graft survival rate has improved from 65% in group A to 75% in group B (p < 0.0001) and to 79% in group C (B versus C, p < 0.0001). Graft half-life was 31 years, overall; it was 41 years for children who survived the first year after transplant. The late annual graft loss rate in teenagers is higher than that in children aged <12 years and similar to that of young adults. No evidence for accelerated graft loss after age 18 years was found.

CONCLUSIONS:

Pediatric liver transplantation has reached a high efficacy as a cure or treatment for severe liver disease in infants and children. Grafts that survived the first year had a half-life similar to standard human half-life. Transplantation before or after puberty may be the pivot-point for lower long-term outcome in children. Further studies are necessary to revisit some old concepts regarding transplant benefit (survival time) for small children, the role of recipient pathophysiology versus graft aging, and risk at transition to adult age.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunología del Trasplante / Obtención de Tejidos y Órganos / Trasplante de Hígado / Rechazo de Injerto / Supervivencia de Injerto Límite: Adolescent / Child / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunología del Trasplante / Obtención de Tejidos y Órganos / Trasplante de Hígado / Rechazo de Injerto / Supervivencia de Injerto Límite: Adolescent / Child / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article País de afiliación: Italia